Send the following on WhatsApp
Continue to Chathttps://www.marketscreener.com/quote/stock/BIOFRONTERA-INC-128192403/news/Biofrontera-Inc-Announces-Last-Patient-Enrolled-in-Phase-3-Clinical-Study-Evaluating-Ameluz-R-Pdt-44579974/?utm_source=whatsapp&utm_medium=social&utm_campaign=share